367 related articles for article (PubMed ID: 17086891)
21. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
22. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
Chu KM; Kwok KF; Law SY; Wong J
Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S
Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laudi F; Papantoniou N; Lisgos P; Spiliadi C; Fragou P; Skorda L; Karatapanis S
Helicobacter; 2012 Feb; 17(1):49-53. PubMed ID: 22221616
[TBL] [Abstract][Full Text] [Related]
26. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
27. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.
Iacopini F; Crispino P; Paoluzi OA; Consolazio A; Pica R; Rivera M; Palladini D; Nardi F; Paoluzi P
Dig Liver Dis; 2005 Aug; 37(8):571-6. PubMed ID: 15996628
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
Moayyedi P; Sahay P; Tompkins DS; Axon AT
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):835-40. PubMed ID: 8574714
[TBL] [Abstract][Full Text] [Related]
29. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
[TBL] [Abstract][Full Text] [Related]
30. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
31. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
[TBL] [Abstract][Full Text] [Related]
32. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
34. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
Valooran GJ; Kate V; Jagdish S; Basu D
Scand J Gastroenterol; 2011 Sep; 46(9):1045-50. PubMed ID: 21627398
[TBL] [Abstract][Full Text] [Related]
35. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
36. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Sun WH; Ou XL; Cao DZ; Yu Q; Yu T; Hu JM; Zhu F; Sun YL; Fu XL; Su H
World J Gastroenterol; 2005 Apr; 11(16):2477-81. PubMed ID: 15832421
[TBL] [Abstract][Full Text] [Related]
38. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Matsushima M; Suzuki T; Kurumada T; Watanabe S; Watanabe K; Kobayashi K; Deguchi R; Masui A; Takagi A; Shirai T; Muraoka H; Kobayashi I; Mine T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):232-6. PubMed ID: 16460479
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
Chuah SK; Hsu PI; Chang KC; Chiu YC; Wu KL; Chou YP; Hu ML; Tai WC; Chiu KW; Chiou SS; Wu DC; Hu TH
Helicobacter; 2012 Jun; 17(3):216-23. PubMed ID: 22515360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
